Patents by Inventor Michael Woerly

Michael Woerly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-fluoro-2-methylbenzo[d]thiazol-5-yl compounds
    Patent number: 10836773
    Abstract: The present invention provides a compound of Formula I: wherein R is hydrogen or methyl; and Z is: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating neurodegenerative diseases, such as Alzheimer's disease.
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: November 17, 2020
    Assignee: Eli Lilly and Company
    Inventors: Nicolas Jacques Francois Dreyfus, Jose Eduardo Lopez, Leonard Larry Winneroski, Jr., Eric Michael Woerly
  • 6-Fluoro-2-Methylbenzo[d]thiazol-5-yl Compounds
    Publication number: 20200354370
    Abstract: The present invention provides a compound of Formula I: wherein R is hydrogen or methyl; and Z is: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating neurodegenerative diseases, such as Alzheimer's disease.
    Type: Application
    Filed: July 28, 2020
    Publication date: November 12, 2020
    Inventors: Nicolas Jacques Francois Dreyfus, Jose Eduardo Lopez, Leonard Larry Winneroski, JR., Eric Michael Woerly
  • 6-fluoro 2-methylbenzo[d]thiazol-5-yl compounds
    Patent number: 10752632
    Abstract: The present invention provides a compound of Formula I: wherein R is hydrogen or methyl; and Z is: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating neurodegenerative diseases, such as Alzheimer's disease.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: August 25, 2020
    Assignee: Eli Lilly and Company
    Inventors: Nicolas Jacques Francois Dreyfus, Jose Eduardo Lopez, Leonard Larry Winneroski, Jr., Eric Michael Woerly
  • 6-Fluoro-2-Methylbenzo[d]thiazol-5-yl Compounds
    Publication number: 20200095254
    Abstract: The present invention provides a compound of Formula I: wherein R is hydrogen or methyl; and Z is: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating neurodegenerative diseases, such as Alzheimer's disease.
    Type: Application
    Filed: September 19, 2019
    Publication date: March 26, 2020
    Inventors: Nicolas Jacques Francois Dreyfus, Jose Eduardo Lopez, Leonard Larry Winneroski, JR., Eric Michael Woerly
  • Animal ear fob
    Patent number: D394227
    Type: Grant
    Filed: September 4, 1996
    Date of Patent: May 12, 1998
    Inventor: Michael Woerly